Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers (clinicaltrials.gov) - Jun 9, 2026 - P1 | N=84 | Recruiting | Sponsor: Daewoong Pharmaceutical Co. LTD. | Trial completion date: Jun 2026 ➔ Mar 2027 | Trial primary completion date: Jun 2026 ➔ Dec 2026
Trial completion date • Trial primary completion date • Immunology
|